Jamjoom Pharmaceuticals Factory Co 2025 AR2
The report details Jamjoom Pharma's strategic, operational, and financial performance for the fiscal year 2025, marking its 25th anniversary. The company achieved a revenue of SAR 1.5 billion, representing a 13.8% year-on-year increase, and a net profit of SAR 463.8 million. Key highlights include the expansion of its regional footprint across 37 countries, the launch of six new brands, and strategic partnerships to localize biopharma manufacturing in Saudi Arabia. On the sustainability front, the company established a three-year Sustainability Strategy, recycled 57% of its waste, and maintained a 46% Saudisation rate.
Company: Jamjoom Pharmaceuticals Factory Co
Sector: Health Care
Country: Saudi Arabia
Year: 2025
Type: AR2
Pages: 128
Jamjoom Pharmaceuticals Factory Co
Annual Report
The report details Jamjoom Pharma's strategic, operational, and financial performance for the fiscal year 2025, marking its 25th anniversary. The company achieved a revenue of SAR 1.5 billion, representing a 13.8% year-on-year increase, and a net profit of SAR 463.8 million. Key highlights include the expansion of its regional footprint across 37 countries, the launch of six new brands, and strategic partnerships to localize biopharma manufacturing in Saudi Arabia. On the sustainability front, the company established a three-year Sustainability Strategy, recycled 57% of its waste, and maintained a 46% Saudisation rate.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Employees